Vamos Q2 2026 slides: fleet utilization hits 89%, profit doubles

Asian stocks declined following a Wall Street tech selloff and investor doubts about artificial intelligence returns. Oil prices held their gains after closing over one hundred dollars, reaching a May high. Treasuries fell and the dollar strengthened as inflation and interest rate hike concerns grew. US President Donald Trump’s threats intensified conflict worries after Houthi…

Despite a subdued Nifty, several Indian stocks have surged, becoming multibaggers for investors. This outperformance is attributed to resilient corporate earnings, particularly in small and mid-cap segments, and company-specific growth drivers. While near-term challenges like rising costs and potential earnings downgrades exist, the overall FY27 outlook remains manageable, with easing geopolitical tensions expected to aid…

Dr Reddy’s Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effects given during surgical procedures. The company’s hospital portfolio expands with this important medicine’s availability. Sugammadex injection is a vertically integrated product manufactured through Dr Reddy’s global network. This launch occurred on the first day of…